Skip links

Info@baebies.com

Call us: +1 (919) 891-0432

Contact Us

Baebies
DX1A5241 Enhanced NR 5 e1741618012975 Baebies

The Baebies Story

Baebies pioneered multifunctional syndromic testing, unfolding new possibilities in rapid, versatile, and accessible diagnostics. Powered by proprietary digital microfluidics technology, Baebies’ approach integrates multiple testing modalities—molecular, immunoassay, chemistry, and coagulation—into a single, compact platform, eliminating the need for separate instruments for each diagnostic function. This breakthrough enables fast, comprehensive results from a small-volume sample, transforming diagnostics across hospitals, clinics, pharmacies, and decentralized care settings.

Baebies was founded with a mission that everyone deserves a healthy start, delivering innovative diagnostics to newborns and children. That mission has now expanded. Recognizing the wider need for rapid and versatile diagnostics across all patient populations, Baebies has evolved to embrace a broader and bolder vision:

Any Test, Anywhere, Everyone.™

This shift reflects Baebies’ dedication to delivering high-quality, multifunctional diagnostics to patients of all ages, wherever testing is needed most.

finder m BaebiesFINDER® is the only multifunctional diagnostic platform with demonstrated capabilities across molecular, immunoassay, chemistry, and coagulation testing. Its ability to generate fast, reliable results from a single small-volume sample is transforming diagnostics across hospitals, clinics, pharmacies, and decentralized care settings. FINDER G6PD chemistry test is FDA-cleared and gaining adoption in hospitals across the U.S. and internationally, broadening access to rapid and reliable diagnostics in diverse healthcare settings. Additional testing modalities in molecular, coagulation, and immunoassays are advancing through clinical studies, further expanding FINDER’s impact in delivering timely, comprehensive patient insights.

In addition, Baebies is developing a next-generation handheld diagnostic platform with the same multifunctional capabilities, designed for even more distributed and accessible use cases.

Baebies has a proven track record of translating early-stage government R&D funding into successful products, leveraging support from organizations such as NIH, CDC, RADx, and BARDA to drive innovation in diagnostics.

FINDER has received industry recognition for its transformative potential. The Association for Diagnostics & Laboratory Medicine (ADLM), in its search for the next innovative testing solution that will transform patient care, awarded FINDER the prestigious Disruptive Technology Award. FINDER also won the People’s Choice Award at ADLM, further reinforcing its role in shaping the future of diagnostics.

20250227 193544859 baebies 1 Baebies

Founded by Vamsee Pamula and Richard West, Baebies has delivered more than 22 million tests, shaping the future of diagnostics and expanding beyond neonatal and pediatric care to serve patients of all ages.

Headquartered in the heart of Research Triangle Park, North Carolina, with a satellite facility in Hyderabad, India, Baebies is bringing advanced testing solutions to more people in more places than ever before.

Baebies is shaping a future where diagnostics are no longer bound by complexity, location, or patient age—because healthcare should work for everyone, everywhere.

Executive Team

Rich Baebies

Richard West | Founder and CEO

With over 20 years of life science CEO experience, Richard leads the strategic direction for Baebies. Previously, Richard and Vamsee Pamula led Advanced Liquid Logic, a Duke spinout that developed lab-on-a-chip technology and products for the research tools and diagnostic markets. Advanced Liquid Logic was sold to Illumina, Inc. for $96M. Prior to Advanced Liquid Logic, Richard was Founder and CEO of TriVirix, a venture-funded medical equipment contract manufacturer that he and his team grew to more than 500 employees. He also spent 15 years in the aerospace industry in program, sales, marketing and engineering management, including four years as a commissioned officer in the US Air Force. Richard is currently on the board and executive committee of NCBIO and serves on a number of private company boards. He has an engineering degree from Duke University, an MBA from the University of West Florida and completed all requirements except dissertation for a PhD in management at the Peter F. Drucker Graduate School of Management.

Vamsee Baebies

Vamsee Pamula, PhD | Founder and President

Vamsee has years of experience with digital microfluidic technology and focuses on the product pipeline and development for Baebies. Formerly, Vamsee partnered with Richard West to develop and then sell Advanced Liquid Logic – a Duke spinout that developed lab-on-a-chip technology and products for the research tools and diagnostic markets – to Illumina, Inc. for $96M. Vamsee has served as a Principal Investigator on several projects funded by the National Institutes of Health (NIH) and led numerous talks on digital microfluidics. He has published more than 60 articles, authored five book chapters and a book, and has more than 200 issued patents and pending patent applications. Vamsee also serves as an Adjunct Professor at Duke University. He has a PhD in Electrical and Computer engineering from Duke University.

Vijay Baebies

Vijay Srinivasan, PhD | VP, Product Development

Vijay has served as Vice President, Product Development since December 2014 and is responsible for managing the Baebies product portfolio. Previously, Vijay was an Associate Director of Engineering at Illumina. Prior to Illumina, Vijay was Director of Engineering at Advanced Liquid Logic, which was sold to Illumina in 2013. Vijay has served as Principal Investigator on several projects funded by the NIH, has published more than 50 articles and authored a book chapter. He has more than 80 issued patents and more than 70 pending patent applications. He has a PhD in electrical and computer engineering from Duke University.

Rama Baebies

Rama Sista, PhD | Vice President, Point of Care Products

Rama joined Baebies in February 2015 and has been serving as the Sr. Director of Systems Engineering and is responsible for integrating engineering sub-components and digital microfluidic cartridges with biochemical assays. Prior to Baebies, he was the Lead Systems Engineer at Illumina and Head of Systems Engineering at Advanced Liquid Logic Inc where he led the development of the SEEKER system. Currently he also serves as the Head of Point of Care Business Unit and leading the development of the FINDER system. He has published over 15 articles and a book chapter and has over 20 pending and approved patents. He has a PhD in Chemical Engineering from Florida State University

Thomas Baebies

Tom Carter | Vice President, Operations

Tom has served as Vice President, Operations since May 2022.  Tom comes to Baebies after 14 years in engineering and capital program leadership roles at Becton Dickenson and Corning Life Sciences.  Prior to those roles, he worked two decades in the fiber optic cable industry leading manufacturing operations and introducing novel manufacturing technologies.  Tom has a successful track record transforming organizations, supporting top-line growth, and delivering bottom-line savings.  Since joining Baebies, Tom has concentrated his efforts on achieving efficient and predictable manufacturing operations through the application of Sales and Operations Planning, ERP, and improved process engineering methods.  His team is focused on the timely introduction of technologies and automation to improve yield and expand manufacturing capacity.  Tom earned BS and MS degrees in Mechanical Engineering and Materials Science at Duke University.

Rainer Baebies

Rainer Ng, PhD | Senior Director, Technology Development

Rainer Ng, Ph.D. leads the Technology Development team at Baebies and oversees all research initiatives at the company. His team of scientists and engineers develop the assays, platforms and enabling technologies needed to advance Baebies’ product pipeline. Dr. Ng manages our relationships with external research partners including the NIH, RADx, BARDA, DoD, and numerous collaborators at hospitals and universities. Dr. Ng serves as an active reviewer in study sections and regularly presents Baebies’ latest scientific achievements at conferences. He holds a Ph.D. in Biomedical Engineering from the University of Michigan and has performed post doctoral research at the University of Washington, Seattle.  Dr. Ng has been part of the Baebies team since 2015. Prior to Baebies, Dr. Ng was a project leader in GlaxoSmithKline’s muscle-metabolism drug discovery program.

Board of Directors

Rich Baebies

Richard West | Founder and CEO

With over 20 years of life science CEO experience, Richard leads the strategic direction for Baebies. Previously, Richard and Vamsee Pamula led Advanced Liquid Logic, a Duke spinout that developed lab-on-a-chip technology and products for the research tools and diagnostic markets. Advanced Liquid Logic was sold to Illumina, Inc. for $96M. Prior to Advanced Liquid Logic, Richard was Founder and CEO of TriVirix, a venture-funded medical equipment contract manufacturer that he and his team grew to more than 500 employees. He also spent 15 years in the aerospace industry in program, sales, marketing and engineering management, including four years as a commissioned officer in the US Air Force. Richard is currently on the board and executive committee of NCBIO and serves on a number of private company boards. He has an engineering degree from Duke University, an MBA from the University of West Florida and completed all requirements except dissertation for a PhD in management at the Peter F. Drucker Graduate School of Management.

Vamsee Baebies

Vamsee Pamula, PhD | Founder and President

Vamsee has years of experience with digital microfluidic technology and focuses on the product pipeline and development for Baebies. Formerly, Vamsee partnered with Richard West to develop and then sell Advanced Liquid Logic – a Duke spinout that developed lab-on-a-chip technology and products for the research tools and diagnostic markets – to Illumina, Inc. for $96M. Vamsee has served as a Principal Investigator on several projects funded by the National Institutes of Health (NIH) and led numerous talks on digital microfluidics. He has published more than 60 articles, authored five book chapters and a book, and has more than 200 issued patents and pending patent applications. Vamsee also serves as an Adjunct Professor at Duke University. He has a PhD in Electrical and Computer engineering from Duke University.

William Hawkins Baebies

William Hawkins | Retired Chairman & CEO of Medtronic

Bill is retired Chairman and CEO of Medtronic, one of the world’s largest and most innovative medical technology companies. He joined Medtronic in 2002, holding several leadership positions prior to serving as Chairman and CEO. Most recently, Bill was President and CEO of Immucor, a provider of transfusion and transplantation diagnostic products worldwide. Prior to Medtronic, he served as President and CEO of Novoste Corp. (Nasdaq: NOVT) and held senior leadership positions at American Home Products, Johnson & Johnson, Guidant Corp. and Eli Lilly & Co. He began his medical technology career with Carolina Medical Electronics in 1977. Bill is active on public, private and not-for-profit boards including Halyard Health (NYSE: HYH), KeraNetics and the Duke University Health System. He also serves as a member of the Advisory Boards at Arboretum Ventures, Radius Ventures, LLC, HealthQuest Ventures, Accuitive Medical Ventures, A*STAR SERC Cluster Advisory Board in Singapore and the Biomedical Sciences International Advisory Council, Singapore (“BMS IAC”). He received his BS in Electrical and Biomedical Engineering from Duke, where he also conducted medical research in pathology. He then went on to earn an MBA from the Darden School of Business, University of Virginia.

Dennis Baebies

Dennis Sacha | Principal, IAG

Dennis Sacha is a partner at IAG based in Charleston SC.  He focuses on the evaluation of prospective investments, financial analysis, and diligence reviews.  Previously he was a Director at Sherman Financial where he evaluated and priced portfolios of consumer debt, built and maintained predictive models, and managed portfolio analytics. Prior to Charleston, Dennis served for 20 years in the United States Navy as a Pilot and Aviation Engineering Duty Officer.  He has flown operationally as well as holding positions as Information Warfare Assistant, Flight Research Scientist, Avionics Systems Program Manager, and Director of Production for P-3s and Aircraft Engines. Mr. Sacha graduated from the Massachusetts Institute of Technology with a Master of Science and a Bachelor of Science in Aeronautical Engineering.